MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Prostate Cancer Treatment and Research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

3,880 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
3,880 works in the cohort · of 4,299,418page 16 of 78

Labels cover 13 of 3,880 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 3,880 of 3,880 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Results from a phase 3, randomized, double-blind, multicenter, placebo-controlled trial of orteronel (TAK-700) plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) that has progressed during or following docetaxel-based therapy (ELM-PC 5 trial).
Robert Dreicer, Robin L. Jones, Stéphane Oudard, Eleni Efstathiou, Fred Saad, Ronald de Wit +7 more
2014· article· en· Journal of Clinical Oncology· Medicine
distilled prediction:candidate · noneconsensus · none
35
citations
affunlabeled
On cribriform prostate cancer
Charlotte F. Kweldam, Theodorus van der Kwast, Geert J. van Leenders
2018· review· en· Translational Andrology and Urology· Medicine
distilled prediction:candidate · noneconsensus · none
35
citations
affno abstractunlabeled
Prostate Cancer as a Model System for Genetic Diversity in Tumors
Jeremy A. Squire, Paul C. Park, Maisa Yoshimoto, Jennifer Alami, Julia L. Williams, Andrew Evans +1 more
2011· review· en· Advances in cancer research· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
35
citations
afffundno abstractunlabeled
Prognostic prostate tissue biomarkers of potential clinical use
Theodorus van der Kwast
2014· review· en· Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin· Medicine
distilled prediction:candidate · metaepi_narrow+sts+research_integrityconsensus · metaepi_narrow+research_integrity
35
citations
afffundunlabeled
Functional mapping of androgen receptor enhancer activity
Chia-Chi Flora Huang, Shreyas Lingadahalli, Tunç Morova, Doğancan Özturan, Eugene Hu, Ivan Pak Lok Yu +18 more
2021· article· en· Genome biology· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
34
citations

How this was built: Screen · Findings · About